Xavier Kurz

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 20

Top Venues

Pharmacoepidemiology and drug safety

Clinical pharmacology and therapeutics

Clinical epidemiology

European Medicines Agency

This page only lists publications with an associated author ORCID identifier.

Affiliation History

European Medicines Agency

Netherlands

Head of Data Analytics Workstream :: Data Analytics and Methods Task Force

Publications

Vincent Lo Re, Noelle M Cocoros, Rebecca A Hubbard, Sarah K Dutcher, Craig W Newcomb, John G Connolly, Silvia Perez-Vilar, Dena M Carbonari, Maria E Kempner, José J Hernández-Muñoz, Andrew B Petrone, Allyson M Pishko, Meighan E Rogers Driscoll, James T Brash, Sean Burnett, Catherine Cohet, Matthew Dahl, Terese A DeFor, Antonella Delmestri, Djeneba Audrey Djibo, Talita Duarte Salles, Laura B Harrington, Melissa Kampman, Jennifer L Kuntz, Xavier Kurz, Núria Mercadé-Besora, Pamala A Pawloski, Peter R Rijnbeek, Sarah Seager, Claudia A Steiner, Katia M C Verhamme, Fangyun Wu, Yunping Zhou, Edward Burn, J Michael Paterson, Daniel Prieto Alhambra
Risk of Arterial and Venous Thrombotic Events Among Patients with COVID-19: A Multi-National Collaboration of Regulatory Agencies from Canada, Europe, and United States. Clinical epidemiology 16 (2024)
Rosa Gini, Romin Pajouheshnia, Lia Gutiérrez, Morris A Swertz, Eleanor Hyde, Miriam C J M Sturkenboom, Alejandro Arana, Carla Franzoni, Vera Ehrenstein, Giuseppe Roberto, Miguel Gil, Miguel-Angel Maciá-Martínez, Wiebke Schäfer, Ulrike Haug, Nicolas H Thurin, Régis Lassalle, Cécile Droz-Perroteau, Silvia Zaccagnino, Maria Paula Busto, Bas Middelkoop, Karin Gembert, Francisco Sanchez-Saez, Clara L Rodríguez-Bernal, Gabriel Sanfélix-Gimeno, Isabel Hurtado, Manuel Barreiro-de Acosta, Beatriz Poblador-Plou, Jonás Carmona Píréz, Antonio Gimeno-Miguel, Alexandra Prados-Torres, Anna Schultze, Ella Jansen, Ron M C Herings, Josephina G Kuiper, Igor Locatelli, Janja Jazbar, Špela Žerovnik, Mitja Kos, Steven Smit, Sirje Lind, Andres Metspalu, Stefania Simou, Karin Hedenmalm, Ana Cochino, Paolo Alcini, Xavier Kurz, Susanna Perez-Gutthann
Metadata for Data dIscoverability aNd Study rEplicability in obseRVAtional Studies (MINERVA): Lessons Learnt From the MINERVA Project in Europe. Pharmacoepidemiology and drug safety 33 (8) (2024)
Vincent Lo Re, Noelle M Cocoros, Rebecca A Hubbard, Sarah K Dutcher, Craig W Newcomb, John G Connolly, Silvia Perez-Vilar, Dena M Carbonari, Maria E Kempner, José J Hernández-Muñoz, Andrew B Petrone, Allyson M Pishko, Meighan E Rogers Driscoll, James T Brash, Sean Burnett, Catherine Cohet, Matthew Dahl, Terese A DeFor, Antonella Delmestri, Djeneba Audrey Djibo, Talita Duarte Salles, Laura B Harrington, Melissa Kampman, Jennifer L Kuntz, Xavier Kurz, Núria Mercadé-Besora, Pamala A Pawloski, Peter R Rijnbeek, Sarah Seager, Claudia A Steiner, Katia M C Verhamme, Fangyun Wu, Yunping Zhou, Edward Burn, J Michael Paterson, Daniel Prieto Alhambra
Risk of Arterial and Venous Thrombotic Events Among Patients with COVID-19: A Multi-National Collaboration of Regulatory Agencies from Canada, Europe, and United States. Clinical epidemiology 16 (2024)
Romin Pajouheshnia, Rosa Gini, Lia Gutiérrez, Morris A Swertz, Eleanor Hyde, Miriam C J M Sturkenboom, Alejandro Arana, Carla Franzoni, Vera Ehrenstein, Giuseppe Roberto, Miguel Gil, Miguel-Angel Maciá-Martínez, Wiebke Schäfer, Ulrike Haug, Nicolas H Thurin, Régis Lassalle, Cécile Droz-Perroteau, Silvia Zaccagnino, Maria Paula Busto, Bas Middelkoop, Karin Gembert, Francisco Sanchez-Saez, Clara L Rodríguez-Bernal, Gabriel Sanfélix-Gimeno, Isabel Hurtado, Manuel Barreiro-de Acosta, Beatriz Poblador-Plou, Jonás Carmona Píréz, Antonio Gimeno-Miguel, Alexandra Prados-Torres, Anna Schultze, Ella Jansen, Ron M C Herings, Josephina G Kuiper, Igor Locatelli, Janja Jazbar, Špela Žerovnik, Mitja Kos, Steven Smit, Sirje Lind, Andres Metspalu, Stefania Simou, Karin Hedenmalm, Ana Cochino, Paolo Alcini, Xavier Kurz, Susanna Perez-Gutthann
Metadata for Data dIscoverability aNd Study rEplicability in obseRVAtional Studies (MINERVA): Development and Pilot of a Metadata List and Catalogue in Europe. Pharmacoepidemiology and drug safety 33 (8) (2024)
Martin Russek, Chantal Quinten, Valentijn M T de Jong, Catherine Cohet, Xavier Kurz
Assessing heterogeneity of electronic healthcare databases: a case study of background incidence rates of venous thromboembolism. Pharmacoepidemiology and drug safety (2023)
Shirley V Wang, Jesper Hallas, William Crown, Peter Arlett, Darren M Ashcroft, Eric I Benchimol, Marc L Berger, Gracy Crane, Wim Goettsch, Wei Hua, Shaum Kabadi, David M Kern, Xavier Kurz, Sinead Langan, Takahiro Nonaka, Lucinda Orsini, Susanna Perez-Gutthann, Simone Pinheiro, Nicole L Pratt, Sebastian G Schneeweiss, Massoud Toussi, Rebecca J Williams
HARmonized Protocol Template to Enhance Reproducibility of hypothesis evaluating real-world evidence studies on treatment effects: A good practices report of a joint ISPE/ISPOR task force. Pharmacoepidemiology and drug safety (2022)
Luis Correia Pinheiro, Xavier Kurz
Artificial intelligence in pharmacovigilance: A regulatory perspective on explainability. Pharmacoepidemiology and drug safety 31 (12) (2022)
Elisabeth Bakker, Kelly Plueschke, Carla J Jonker, Xavier Kurz, Viktoriia Starokozhko, Peter G M Mol
Contribution of Real-World Evidence in European Medicines Agency's Regulatory Decision Making. Clinical pharmacology and therapeutics (2022)
Peter Arlett, Xavier Kurz, Katherine Soltys, Michael D Blum
International Collaboration in Real-World Evidence Generation for Direct Acting Oral Anti-Coagulants. Clinical pharmacology and therapeutics 109 (2) (2020)
Andrej Segec, Jim Slattery, Daniel R Morales, Justina Januskiene, Xavier Kurz, Peter Arlett
Does additional monitoring status increase the reporting of adverse drug reactions? An interrupted time series analysis of EudraVigilance data. Pharmacoepidemiology and drug safety 30 (3) (2020)
Justina Januskiene, Andrej Segec, Jim Slattery, Georgy Genov, Kelly Plueschke, Xavier Kurz, Peter Arlett
What are the patients' and health care professionals' understanding and behaviors towards adverse drug reaction reporting and additional monitoring? Pharmacoepidemiology and drug safety 30 (3) (2020)
Jesper Hallas, Xavier Kurz, Nicholas Moore, Christian Fynbo Christiansen, Olaf Klungel
Considerations for pharmacoepidemiological analyses in the SARS-CoV-2 pandemic. Pharmacoepidemiology and drug safety 29 (8) (2020)
Robert W V Flynn, Karin Hedenmalm, Tarita Murray-Thomas, Alexandra C Pacurariu, Peter Arlett, Hilary Shepherd, Puja Myles, Xavier Kurz
Ability of Primary Care Health Databases to Assess Medicinal Products Discussed by the European Union Pharmacovigilance Risk Assessment Committee. Clinical pharmacology and therapeutics 107 (4) (2020)
Jim Slattery, Xavier Kurz
Assessing strength of evidence for regulatory decision making in licensing: What proof do we need for observational studies of effectiveness? Pharmacoepidemiology and drug safety 29 (10) (2020)
Rosa Gini, Xavier Fournie, Helen Dolk, Xavier Kurz, Patrice Verpillat, François Simondon, Valerie Strassmann, Kathi Apostolidis, Thomas Goedecke
The ENCePP Code of Conduct: A best practise for scientific independence and transparency in noninterventional postauthorisation studies. Pharmacoepidemiology and drug safety 28 (4) (2019)
Karin Hedenmalm, Kevin Blake, Katherine Donegan, Miguel-Angel Macia, Miguel Gil, Julie Williams, Dolores Montero, Gianmario Candore, Daniel Morales, Xavier Kurz, Peter Arlett
A European multicentre drug utilisation study of the impact of regulatory measures on prescribing of codeine for pain in children. Pharmacoepidemiology and drug safety 28 (8) (2019)
Xavier Kurz, Susanna Perez-Gutthann, null null
Strengthening standards, transparency, and collaboration to support medicine evaluation: Ten years of the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP). Pharmacoepidemiology and drug safety 27 (3) (2018)
Alexandra C Pacurariu, Kelly Plueschke, Carla Alonso Olmo, Xavier Kurz
Imposed registries within the European postmarketing surveillance system: Extended analysis and lessons learned for regulators. Pharmacoepidemiology and drug safety 27 (7) (2018)
Jacoline C Bouvy, Kevin Blake, Jim Slattery, Marie Louise De Bruin, Peter Arlett, Xavier Kurz
Registries in European post-marketing surveillance: a retrospective analysis of centrally approved products, 2005-2013. Pharmacoepidemiology and drug safety 26 (12) (2017)
Xavier Kurz
Advancing regulatory science, advancing regulatory practice. Pharmacoepidemiology and drug safety 26 (6) (2017)

Xavier Kurz.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Xavier Kurz